Egyptian Journal of Chest Diseases and Tuberculosis

Scope & Guideline

Empowering global collaboration for healthier lungs.

Introduction

Explore the comprehensive scope of Egyptian Journal of Chest Diseases and Tuberculosis through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Egyptian Journal of Chest Diseases and Tuberculosis in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN0422-7638
PublisherWOLTERS KLUWER MEDKNOW PUBLICATIONS
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationEGYPT J CHEST DIS TU / Egypt. J. Chest Dis. Tuberc.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressWOLTERS KLUWER INDIA PVT LTD, A-202, 2ND FLR, QUBE, C T S NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, Maharashtra 400059, INDIA

Aims and Scopes

The Egyptian Journal of Chest Diseases and Tuberculosis primarily focuses on advancing the understanding and management of respiratory diseases, with a particular emphasis on tuberculosis and other pulmonary conditions. The journal aims to disseminate high-quality research that contributes to the fields of pulmonology and respiratory medicine.
  1. Pulmonary Infectious Diseases:
    The journal emphasizes research on infectious diseases affecting the lungs, particularly tuberculosis, COVID-19, and other respiratory infections. This includes studies on diagnosis, treatment, and management strategies.
  2. Chronic Respiratory Diseases:
    Research on chronic conditions such as chronic obstructive pulmonary disease (COPD), asthma, and interstitial lung diseases is a core focus. The journal publishes studies that investigate pathophysiology, management, and rehabilitation of these diseases.
  3. Diagnostic Innovations:
    There is a strong focus on novel diagnostic techniques, including imaging (e.g., ultrasound, CT), biomarker studies, and advanced laboratory methods for detecting respiratory diseases, which contribute to better patient outcomes.
  4. Therapeutic Interventions:
    The journal covers a range of therapeutic approaches, including pharmacological treatments, surgical interventions, and rehabilitation strategies. It particularly addresses the effectiveness of new therapies and treatment protocols.
  5. Occupational and Environmental Health:
    The impact of occupational exposures and environmental factors on respiratory health is explored, particularly in relation to specific populations such as healthcare workers and industrial workers.
  6. Public Health and Epidemiology:
    The journal also includes studies on the epidemiology of respiratory diseases, public health initiatives, and strategies for controlling infectious diseases within communities.
The Egyptian Journal of Chest Diseases and Tuberculosis has identified several emerging themes that reflect current trends in respiratory medicine and public health. These topics are increasingly relevant and highlight the journal's adaptability to contemporary challenges.
  1. COVID-19 Research:
    There is a significant increase in publications related to COVID-19, focusing on its respiratory complications, long-term effects, and management strategies, which have become critical due to the pandemic.
  2. Antimicrobial Resistance:
    Research on antimicrobial resistance, particularly in tuberculosis and other respiratory pathogens, is gaining prominence as global health authorities prioritize combating drug-resistant infections.
  3. Telemedicine and Remote Monitoring:
    The rise of telemedicine, particularly in managing respiratory diseases during the pandemic, is reflected in recent publications, emphasizing the need for innovative care delivery models.
  4. Personalized Medicine:
    Emerging studies on personalized medicine approaches in treating respiratory diseases, including the use of biomarkers for targeted therapies, are increasingly featured.
  5. Public Health Interventions:
    There is a growing emphasis on studies related to public health interventions aimed at controlling respiratory diseases, including vaccination campaigns and community health strategies.
  6. Occupational Health Studies:
    Research examining the effects of occupational exposures on respiratory health is trending, particularly studies involving specific professions and environmental impacts.

Declining or Waning

While the journal maintains a diverse range of topics, certain areas have shown a declining frequency of publication over recent years. These waning themes may reflect shifts in research focus or changes in clinical relevance.
  1. Traditional Diagnostic Methods:
    There has been a noticeable decrease in studies focusing solely on conventional diagnostic methods such as basic spirometry and chest X-rays, as the field moves towards more advanced imaging and molecular techniques.
  2. Tuberculosis Treatment Protocols:
    Research specifically on older protocols for tuberculosis treatment appears to be declining, possibly due to the increasing focus on drug resistance and novel therapeutic regimens.
  3. Pediatric Respiratory Conditions:
    The focus on pediatric respiratory diseases, while still important, has diminished in favor of adult respiratory health issues, particularly in the context of chronic diseases and COVID-19.
  4. Non-communicable Respiratory Diseases:
    Research on non-communicable diseases of the lungs, such as lung cancer, has seen a relative decline in favor of infectious diseases, particularly in light of the recent COVID-19 pandemic.

Similar Journals

Annals of the American Thoracic Society

Elevating clinical practice through impactful research and methodologies.
Publisher: AMER THORACIC SOCISSN: 1546-3222Frequency: 12 issues/year

Annals of the American Thoracic Society is a premier journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by the American Thoracic Society, this journal offers an invaluable platform for researchers and clinicians to disseminate cutting-edge research, clinical insights, and innovative methodologies. With an impressive impact factor and ranked in the top Q1 category of its field (2023) and within the top 20 of 155 according to Scopus rankings, it is positioned as a leading force in shaping clinical practice and research directions. The journal's convergence years from 2013 to 2024 indicate a commitment to providing timely and relevant content at the forefront of pulmonary health. While not an open-access journal, it ensures broad accessibility to its significant contributions in respiratory medicine, making it an essential resource for professionals, researchers, and students alike endeavoring to deepen their understanding and improve outcomes in thoracic health.

Journal of Thoracic Disease

Exploring the forefront of pulmonary medicine.
Publisher: AME PUBLISHING COMPANYISSN: 2072-1439Frequency: 12 issues/year

Welcome to the Journal of Thoracic Disease, a premier scholarly journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by AME PUBLISHING COMPANY in Hong Kong, this journal has established itself as a critical platform for the dissemination of innovative research and clinical advancements since its inception in 2009. With an impressive Q2 ranking in the Scopus category of Pulmonary and Respiratory Medicine, it is recognized for its contribution to the academic community, featuring a broad range of original research, reviews, and case studies that address contemporary challenges in thoracic disease management. The journal is committed to Open Access principles, ensuring that high-quality research is readily available to a global audience, further enhancing its impact factor and reach. Researchers, healthcare professionals, and students alike will find invaluable insights within its pages, making Journal of Thoracic Disease an essential resource for those invested in the respiratory health domain.

Indian Journal of Respiratory Care

Advancing Respiratory Health Through Open Access Research
Publisher: JAYPEE BROTHERS MEDICAL PUBLISHERS PVT LTDISSN: 2277-9019Frequency: 4 issues/year

Welcome to the Indian Journal of Respiratory Care, a premier platform dedicated to advancing research and clinical practices in the field of respiratory health. Published by JAYPEE BROTHERS MEDICAL PUBLISHERS PVT LTD, this journal has established itself as a crucial resource for researchers, healthcare professionals, and educators since embracing an Open Access model in 2012, ensuring maximum visibility and accessibility of vital research findings. The journal aims to disseminate high-quality articles encompassing a wide range of topics, including but not limited to, respiratory diseases, pulmonary care, and innovative treatment approaches. With its commitment to fostering collaboration and knowledge exchange, the Indian Journal of Respiratory Care is poised to make a significant impact in the ever-evolving landscape of respiratory medicine. As the field continues to grow, this journal serves as an essential touchpoint for those invested in enhancing patient care and outcomes.

Pulmonology

Elevating knowledge and practice in pulmonary medicine.
Publisher: ELSEVIERISSN: 2531-0437Frequency: 6 issues/year

Pulmonology, an esteemed journal published by Elsevier, serves as a vital platform for advancing knowledge in the field of Pulmonary and Respiratory Medicine. Since its transition to Open Access in 2018, this journal has successfully fostered a global readership, allowing for unrestricted dissemination of cutting-edge research. With an impressive Scopus ranking of #8 out of 155 in its category and a notable 2023 Q1 status, Pulmonology consistently showcases high-quality studies and reviews that contribute to the understanding and treatment of respiratory disorders. Authors and readers alike benefit from its commitment to publish influential research that addresses contemporary challenges in lung health. By bridging the gap between theory and clinical practice, the journal paves the way for innovative practices in pulmonology, making it an indispensable resource for researchers, healthcare professionals, and students interested in this dynamic field.

Egyptian Journal of Bronchology

Advancing respiratory health through open access research.
Publisher: SPRINGERISSN: 1687-8426Frequency: 4 issues/year

Egyptian Journal of Bronchology, published by SPRINGER, is a premier open access journal dedicated to advancing the field of respiratory medicine, particularly focusing on bronchial diseases and disorders. Since its establishment in 2013, this journal has provided a platform for the dissemination of high-quality research articles, systematic reviews, and clinical studies, making significant contributions to the understanding and management of bronchological conditions. With its commitment to open access, the journal ensures that research findings are readily available to a global audience, fostering knowledge exchange among researchers, healthcare professionals, and students alike. The Egyptian Journal of Bronchology serves as an essential resource in the field, reflecting a growing emphasis on accessible scientific knowledge and collaborative research in respiratory health.

Multidisciplinary Respiratory Medicine

Advancing respiratory health through collaborative research.
Publisher: MATTIOLI 1885ISSN: 1828-695XFrequency: 1 issue/year

Multidisciplinary Respiratory Medicine is a leading open-access journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by MATTIOLI 1885, this journal has been serving the academic community since 2008 and has become a vital platform for the dissemination of research and clinical insights in this critical area of healthcare. With an impressive impact factor placing it in the Q2 category of pulmonary medicine in 2023 and a Scopus rank of #67 out of 155, it reflects a solid commitment to high-quality research. The journal provides researchers, health professionals, and students with accessible and updated information, fostering collaboration and advancement in respiratory health. Operating from the United Kingdom, it has embraced open access since 2010, ensuring that all articles are freely available, thus maximizing the reach and impact of its scholarly contributions. Whether you are looking to publish innovative findings or gain insights from industry leaders, Multidisciplinary Respiratory Medicine is your go-to resource for the latest in respiratory science.

Pulmonary Medicine

Fostering Collaboration for a Healthier Tomorrow
Publisher: HINDAWI LTDISSN: 2090-1836Frequency: 1 issue/year

Pulmonary Medicine, published by HINDAWI LTD, stands as a prestigious open-access journal since 2010, dedicated to advancing the field of pulmonary and respiratory medicine. Located in Egypt, this journal is indexed with an ISSN of 2090-1836 and an E-ISSN of 2090-1844, and it has attained a commendable Q2 ranking in both the miscellaneous medicine and pulmonary health categories, indicative of its significant impact and quality. With an impressive Scopus ranking of #15 out of 155 in the pulmonary and respiratory medicine category, the journal is positioned in the 90th percentile, highlighting its relevance and contribution to ongoing research. The journal aims to publish high-quality original research, reviews, and clinical studies that address pressing issues in pulmonary health, making it a vital resource for researchers, clinicians, and students seeking to enhance their understanding and practice in respiratory medicine. By embracing an open-access model, Pulmonary Medicine provides a platform for disseminating knowledge, fostering collaboration, and driving innovation within the global scientific community.

Zeitschrift fur Pneumologie

Pioneering Discoveries in Respiratory Medicine
Publisher: SPRINGER HEIDELBERGISSN: 2731-7404Frequency: 6 issues/year

Zeitschrift für Pneumologie is a pivotal journal in the field of Pulmonary and Respiratory Medicine, published by Springer Heidelberg, a renowned name in academic publishing. With its ISSN number 2731-7404, it serves as a vital platform for disseminating innovative research and clinical studies relevant to lung health and diseases. This German-based journal aims to bridge the gap between research and practice, encouraging submissions that advance knowledge in respiratory medicine, including pathophysiology, treatment modalities, and patient care strategies. Although currently categorized in the Q4 quartile within its field, its commitment to quality research and emerging insights positions it as an essential resource for researchers, healthcare professionals, and students dedicated to improving respiratory health. The journal operates within the convergence period from 2022 to 2024, promising a dynamic evolution of its content. With limited open access availability, it encourages readership and contribution from its audience, fostering a collaborative academic environment.

RESPIRATION

Championing Excellence in Pulmonary Science
Publisher: KARGERISSN: 0025-7931Frequency: 12 issues/year

RESPIRATION is a prestigious journal dedicated to advancing knowledge in the field of Pulmonary and Respiratory Medicine, with a commitment to publishing high-quality, peer-reviewed research. Established in 1944 and published by KARGER in Switzerland, this journal has maintained an exemplary impact within the scientific community, currently holding a Q1 ranking in the 2023 category for Pulmonary and Respiratory Medicine, placing it among the top 18% of journals in its field. With an ISSN of 0025-7931 and an E-ISSN of 1423-0356, RESPIRATION provides a platform for researchers and professionals to disseminate original studies, reviews, and clinical cases that shape contemporary understanding and treatment of respiratory diseases. The journal's rigorous standards for publication ensure that it remains a vital resource for the latest innovations and findings. As part of its mission, RESPIRATION seeks to bridge the gap between clinical practice and research, fostering multidisciplinary collaboration and enhancing patient outcomes. The journal is readily accessible, ensuring that vital research reaches a broad audience of healthcare professionals and academic scholars globally.

Monaldi Archives for Chest Disease

Elevating Research Standards in Chest Disease
Publisher: PAGEPRESS PUBLISSN: 1122-0643Frequency: 3 issues/year

The Monaldi Archives for Chest Disease, published by PAGEPRESS PUBL, is a vital resource for researchers and healthcare professionals dedicated to the fields of cardiology and pulmonary medicine. With an ISSN of 1122-0643 and an E-ISSN of 2532-5264, this Open Access journal has been committed to disseminating high-quality research since 2004, ensuring that findings in chest disease are easily accessible to a global audience. Based in Italy, the journal features contributions that reflect a broad scope of topics within its fields, achieving a Q3 ranking in both Cardiology and Cardiovascular Medicine, as well as in Pulmonary and Respiratory Medicine as of 2023. The journal's Scopus ranks place it at 168th out of 387 in its cardiology category and 83rd out of 155 in pulmonary medicine, indicating its relevance in the academic landscape. With its commitment to advancing knowledge and practice, the Monaldi Archives for Chest Disease stands as an essential platform for publication and dialogue in chest disease research, appealing to a diverse audience of scholars and practitioners.